Organon & Co. (OGN)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenues | 1,594 | 1,513 | 1,582 | 1,607 |
| Cost of sales | 720 | 672 | 659 | 668 |
| Gross profit | 874 | 841 | 923 | 939 |
| Exchange (gains) losses | 1 | 4 | -6 | 1 |
| Other (income) expense, net | 35 | -12 | - | -6 |
| Interest expense | 131 | 124 | 126 | 131 |
| Acquired in-process research and development and milestones | - | 6 | 51 | 15 |
| Research and development | 95 | 96 | 111 | 116 |
| Restructuring costs | 2 | 86 | - | - |
| Selling, general and administrative | 453 | 420 | 422 | 437 |
| Income before income taxes | 229 | 101 | 207 | 235 |
| Income tax expense | 84 | 14 | -152 | 40 |
| Net income | 145 | 87 | 359 | 195 |
| Basic (in dollars per share) | 0.56 | 0.34 | 1.39 | 0.76 |
| Basic (in shares) | 259,939,000 | 257,862,000 | 257,498,000 | 257,288,000 |
| Diluted (in dollars per share) | 0.56 | 0.33 | 1.38 | 0.75 |
| Diluted (in shares) | 260,156,000 | 261,001,000 | 259,757,000 | 258,598,000 |